This inventor holds 1 USPTO granted patent. Top assignee: Zentiva K.s.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovations of Peter Babiak
Introduction
Peter Babiak is a notable inventor based in Prešov, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly with his work on Canagliflozin. His innovative approach has led to advancements in medication that can benefit many patients.
Latest Patents
Peter Babiak holds a patent for a new crystalline form of Canagliflozin and a method of its preparation. This invention relates to a new crystalline form of Canagliflozin, which is a compound used in the treatment of diabetes. The systematic name of this compound is (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. This patent showcases his expertise in developing pharmaceutical formulations.
Career Highlights
Peter Babiak is associated with Zentiva, a prominent pharmaceutical company. His work at Zentiva has allowed him to focus on innovative drug development and contribute to the advancement of medical science. His dedication to research and development has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Peter has collaborated with talented individuals such as Josef Zezula and Ondřej Dammer. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Peter Babiak's contributions to the field of pharmaceuticals, particularly through his patent on Canagliflozin, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations.